Chiltern International Limited (Chiltern) has entered into a global partnership agreement with EPS International Co., Ltd. to exchange their expertise is clinical development
Chiltern International Limited (Chiltern), a global Clinical Research Organization (CRO) that provides clinical development and staffing services in Europe, North America, Latin America and India, had entered into a global partnership agreement with EPS International Co., Ltd., a wholly owned subsidiary of EPS Co., Ltd., a leading provider of a clinical development services in the Asian region.
Chiltern will provide services to EPS International from their network of offices in 23 countries throughout Europe, North America, South America and India. Similarly, EPS International will provide clinical development services for the Asian region from their offices in Japan, China, Singapore, Korea and Taiwan.
Asia is becoming an increasingly attractive market for clinical trial services and finding a partner with a meaningful presence and experience of conducting clinical trials throughout Southeast Asia is an important development for Chiltern. With EPS as the company’s partner in this region the focus is to deliver expert, high quality, clinical development services around the world.